Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
01/2008
01/30/2008CN101115724A Inhibitors of checkpoint kinases
01/30/2008CN101115717A Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
01/29/2008CA2312885C 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
01/24/2008WO2008009348A1 A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles
01/24/2008WO2007128086A3 Novel viral replication inhibitor
01/24/2008WO2007076245A3 Novel hydrogen sulfate salt
01/24/2008US20080021201 Protease inhibitor conjugates and antibodies useful in immunoassay
01/24/2008US20080021082 Small molecule inhibition of a PDZ-domain interaction
01/24/2008US20080021069 Receptor Function Regulating Agent
01/24/2008US20080021027 Novel benzimidazole derivatives
01/24/2008CA2657717A1 A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles
01/23/2008EP1879577A1 Proton pump inhibitors in the treatment of sleep disturbance due to silent gastro-esophageal reflux
01/23/2008EP1879564A2 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus
01/23/2008EP1521755B1 Novel diketopyrrolopyrrole pigments
01/22/2008US7320995 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole
01/22/2008CA2305807C Substituted fused heterocyclic compounds
01/17/2008WO2008007780A1 Pentadienamide derivative
01/17/2008US20080015360 2,3-Dimethyl-1-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-imidazol-3-ium chloride; intermediate for preparing androstane-type glucocorticoid receptor agonists
01/17/2008US20080015359 Process for the Preparation of Telmisartan
01/17/2008US20080015256 Tetralin and indane derivatives and uses thereof
01/17/2008US20080015222 New Heterocyclic Amides
01/17/2008US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof
01/17/2008US20080015178 Benzimidazoles, process for their preparation and use thereof as medicament
01/17/2008CA2658097A1 Pentadienamide derivatives
01/16/2008EP1878724A1 A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles
01/16/2008EP1877364A1 Phenylacetylene derivatives having mglur5 receptor affinity
01/16/2008EP1644320B1 Indane derivates as muscarinic receptor agonists
01/16/2008CN101107231A Imidazole and benzimidazole derivatives useful as histamine H3 antagonists
01/15/2008US7319110 1H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activity
01/15/2008US7318966 Luminescent element material and luminescent element comprising the same
01/10/2008WO2008003752A1 2 -amino benzimidazole derivatives and their use as modulators of small - conductance calcium -act ivated potassium channels
01/10/2008WO2006108488A8 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents
01/10/2008US20080009520 Benzimidazolidinone derivatives as muscarinic agents
01/10/2008US20080009506 Imidazole Compound
01/10/2008US20080009493 Substituted Benzimidazoles and Imidazo-[4,5]-Pyridines
01/10/2008US20080009488 protein kinase inhibitors such as Methyl {5-[2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl]-1H-benzimidazol-2-yl}carbamate, used to modulate cellular activities such as proliferation, differentiation, apoptosis, migration and chemoinvasion
01/10/2008CA2648520A1 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications
01/09/2008EP1874770A1 Phenylacetamides suitable as protein kinase inhibitors
01/09/2008EP1874758A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
01/09/2008EP1874737A1 Substituted 2-amin0alkylthi0-benzimidaz0les and use thereof for reducing blood sugar levels
01/09/2008EP1874736A2 Fused heterocyclic compounds
01/09/2008EP1874735A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
01/09/2008EP1874733A1 Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators
01/09/2008EP1732887B1 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity and the monoamine reuptake for the treatment of vasomotor symptoms (vms)
01/09/2008EP1653950B1 Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases
01/09/2008EP1402890B1 Sulfonamide derivatives
01/09/2008CN101103022A New carboxylic acid amide used as XA inhititor
01/09/2008CN101103018A Compounds for the treatment of CNS and amyloid associated diseases
01/09/2008CN101100458A Bibenzimidazole derivative with PPARgamma exciting agent activity and application thereof
01/09/2008CN100360540C Preparation of polyphenol oxidase model compound and use
01/09/2008CN100360499C Propanoic acid derivatives that inhibit binding of integrins to their receptors
01/03/2008WO2008000643A1 Benzimidazole derivatives, method for the production thereof, their use as fxr agonists and pharmaceutical preparations containing the same
01/03/2008WO2007122341A3 Specific monocationic monochromophoric hydrazone compounds containing a 2-(benz)imidazolium unit, their synthesis, dyeing compositions comprising them, method of dyeing keratin fibres
01/03/2008US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
01/03/2008US20080004290 Anti-Cancer Agents
01/03/2008US20080004280 Heterocyclic topoisomerase poisons
01/03/2008US20080004270 3,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) Inhibitors
01/03/2008US20080004262 2,2,7,9-tetramethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol; 3-hydroxy-2,2,9-trimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-7-carbonitrile; have the prolongation effect on refractory period
01/03/2008US20080004251 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor
01/03/2008US20080001534 Methods of making tris(N-aryl benzimidazoles)benzenes and their use in electronic devices
01/02/2008EP1871764A1 A synthesis of 4-bromomethyl-2'-formylbiphenyl and 4-bromomethyl-2'- hydroxymethylbiphenyl and its use in preparation of angiotensin ii antagonists
01/01/2008US7314940 For therapy and prophylaxis of neurodegenerative disorders related to apoptosis and/or inflammation
01/01/2008US7314937 Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses
01/01/2008US7314935 Optically pure dihydroimidazo[1,2-h][1,7]naphthyridine intermediates for tetrahydroimidazo[1,2-h][1,7]naphthyridine gastrointestinal antisecretory agents; 7-Acetoxy-10-acetyl-2,3-dimethyl-9-phenyl-9,10-dihydroimidazo[1,2-h][1,7]naphthyridine
01/01/2008US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1
12/2007
12/27/2007WO2007147889A2 Preparation of telmisartan salts
12/27/2007WO2007147771A2 Tetralin and indane derivatives and uses thereof
12/27/2007WO2007115077A3 Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor potentiators
12/27/2007US20070299114 Biaryl Derivatives
12/27/2007US20070299074 Guanidine Compounds, and Use Thereof as Binding partners for 5-Ht5 Receptors
12/27/2007US20070299073 Imidazolyl derivatives
12/27/2007US20070299063 N3 alkylated benzimidazole derivatives as mek inhibitors
12/27/2007CA2653758A1 Tetralin and indane derivatives and uses thereof
12/26/2007EP1870438A1 Phthalocyanine compound, process for producing the same, and colored composition containing the phthalocyanine compound
12/26/2007EP1870408A1 Novel process for producing ramosetron or its salt
12/26/2007EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors
12/26/2007EP1869052A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
12/26/2007EP1869004A1 Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use
12/26/2007EP1539708B1 Benzimidazolones and their use as cytokine inhibitors
12/26/2007EP0804428B1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
12/26/2007CN101094838A Tubulin binding anticancer agents and prodrugs thereof
12/26/2007CN101094837A Novel beta agonists, method for producing the same and their use as drugs
12/26/2007CN101092400A 黄嘌呤氧化酶抑制剂 Xanthine oxidase inhibitors
12/25/2007US7312230 Carboxylic acid derivatives as IP antagonists
12/21/2007WO2007145563A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007WO2007143822A1 Sulfamide and sulfamate derivatives as histone deacetylase inhibitors
12/21/2007CA2654250A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007CA2653039A1 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
12/20/2007US20070293682 Methods of Preparing Sulfinamides and Sulfoxides
12/20/2007US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
12/20/2007US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
12/20/2007US20070292513 Pazopanib hydrochloride and synthesis, chemical intermediates, and dosage forms thereof; anticancer; colon cancer, breast cancer
12/19/2007EP1867684A1 Coloring matter for anisotropic coloring matter film, composition comprising said coloring matter, anisotropic coloring matter film, and polarizing element
12/19/2007EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/19/2007CN101090893A New imidazole derivatives, preparation method thereof and organic electronic device using the same
12/18/2007US7309793 Benzopyran derivatives substituted with a benzimidazole derivative, pharmaceutically acceptable salts therof, their preparations and pharmaceutical compositions containing them
12/18/2007US7309716 Inhibitors of voltage-gated sodium channels; acute, chronic, neuropathic, or inflammatory pain such as femur cancer pain; non-malignant chronic bone pain; rheumatoid arthritis; osteoarthritis; spinal stenosis; neuropathic low back pain; neuropathic low back pain; myofascial pain syndrome; fibromyalgia
12/13/2007WO2007141473A1 N-(benzoyl)-o- [2- (pyridin- 2 -ylamino) ethyl] -l-tyrosine derivatives and related compounds as a5b1 antagonists for the treatment of solid tumors
12/13/2007WO2007141441A1 Improved monomers and polymers carrying imidazole and benzimidazole groupings, and proton exchange membrane containing the same for the production of a fuel cell
12/13/2007US20070287840 Process for Preparing Telmisartan
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 154